RxDoctor Payments Data

Alan Aiken, DO

Orthopaedic Surgery · Johnson City, TNNPI 1437565074

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (50.8%), grants and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Arthrex at 51.7% of the total. Reporting peaked in 2019 at $34,406 and has fallen 98.3% since, to $586 in 2025.

$45,022in general payments, 2019–2025

Across 36 payments — averaging $1250.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$23K
  • Smith+Nephew$16K
  • ALON Medical Technology$4K
  • Stryker$997
  • Johnson & Johnson$141
  • Masimo Corporation$36

What the payments were for

  • Speaking & faculty fees$560%
  • Grants$20,00044%
  • Travel & lodging$9942%
  • Food & beverage$1,0992%
  • Education$22,87351%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex8$23,266
Smith+Nephew7$16,495
ALON Medical Technology3$4,088
Stryker(2 entities)16$997
Johnson & Johnson1$141
Masimo Corporation1$36

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,022 in reported general payments places this provider in the 85th percentile of 381 orthopaedic surgery providers in Tennessee.

See all orthopaedic surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$192,928
Medicare patients
320
Services billed
6,165

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam525$1,289
Naloxone Hcl13$749
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen54$483
Methylprednisolone42$340
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$188
Methocarbamol12$131
Ondansetron Hcl35$109
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim26$100
Ondansetron OdtOndansetron20$88
Tramadol Hcl15$42
Amoxicillin18$22
Clindamycin Hcl16$13

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Johnson City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →